Back to News
Feb 2, 2026 12:01 PM

Wrap Raises $5 Million to Restart Manufacturing

MIAMI, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Wrap Technologies, Inc. (NASDAQ:WRAP) ("Wrap" or, the "Company"), a global leader in non-lethal response solutions, today announced that it entered into a securities purchase agreement for a $5 million private placement. The capital raise is expected to enable the Company to restart domestic manufacturing, advance validated R&D programs into commercialization, and responsibly accelerate early growth initiatives aligned with rising demand for non-lethal response capabilities.

Market Opportunity

Wrap's market opportunity extends beyond a single-device business model to an integrated response platform that combines technology, training, and policy. This is expected to expand the Company's addressable market by positioning Wrap as a Non-Lethal Response provider, delivering system-level capabilities rather than standalone tools across state, local, and federal agencies, as well as select private-sector and commercial security environments where non-lethal, low-risk response solutions are increasingly required.

As part of this transition, the Company is reengaging select manufacturers and key suppliers to support resumed production, future innovation, and supporting management's outlook.

Manufacturing Restart and Quality Controls

Wrap is restarting domestic manufacturing with a renewed focus on rigorous quality control standards for its Non-Lethal Response technologies. This is expected to include the return of experienced quality and production personnel who were integral to earlier high-reliability manufacturing runs, as well as the reimplementation of proven inspection, testing, and process controls. These efforts reflect the Company's emphasis on precision, durability, and consistency as it prepares for expanded deployments across domestic and federal markets.

Training Expansion and Operational Readiness

In parallel, Wrap is increasing domestic training capacity to support broader adoption of Non-Lethal Response programs. Training is expected to be delivered through a tiered model that includes lead instructors, train-the-trainer certification, and hybrid delivery combining in-person and digital instruction for all operators of its expanded Non-Lethal Response technologies. The training expansion is expected to focus on operational integration, lawful control, and scenario-based readiness, ensuring agencies may have the opportunity to deploy non-lethal tools effectively and safely in real-world conditions.

Research and Development and Product Commercialization

Many of Wrap's recent R&D initiatives have progressed through testing and are now entering final validation stages. Additional capital is required to bring these capabilities to market, including next-generation multi-shot systems, drone-enabled non-lethal delivery concepts, and other supporting technologies designed to provide low-collateral, non-lethal options across a wider range of operational environments.

Federal and International Expansion

These investments are expected to support the continued expansion of Wrap Federal, the Company's federal and international business segment focused on U.S. government agencies and allied operations requiring non-lethal, low-collateral solutions. Wrap sees growing opportunity across federal, defense-adjacent, and international use cases where early, non-lethal intervention may improve outcomes while preserving mission readiness.

Leadership Commentary

"Our focus is on adding the resources required to accelerate growth, particularly across manufacturing, quality control, marketing, and R&D," said Scot Cohen, CEO of Wrap. "This capital may allow us to take proven concepts, finalize validation, and responsibly bring them to market, while restoring manufacturing excellence and expanding training to meet real operational demand."

Private Placement

Under the terms of the securities purchase agreement, the Company agreed to issue 2,500,000 shares of common stock at a purchase price of $2.00 per share of common stock (or per pre-funded ...